567 related articles for article (PubMed ID: 11820058)
41. Genotype and clinical care correlations in craniosynostosis: findings from a cohort of 630 Australian and New Zealand patients.
Roscioli T; Elakis G; Cox TC; Moon DJ; Venselaar H; Turner AM; Le T; Hackett E; Haan E; Colley A; Mowat D; Worgan L; Kirk EP; Sachdev R; Thompson E; Gabbett M; McGaughran J; Gibson K; Gattas M; Freckmann ML; Dixon J; Hoefsloot L; Field M; Hackett A; Kamien B; Edwards M; Adès LC; Collins FA; Wilson MJ; Savarirayan R; Tan TY; Amor DJ; McGillivray G; White SM; Glass IA; David DJ; Anderson PJ; Gianoutsos M; Buckley MF
Am J Med Genet C Semin Med Genet; 2013 Nov; 163C(4):259-70. PubMed ID: 24127277
[TBL] [Abstract][Full Text] [Related]
42. Syndromic craniosynostosis: from history to hydrogen bonds.
Cunningham ML; Seto ML; Ratisoontorn C; Heike CL; Hing AV
Orthod Craniofac Res; 2007 May; 10(2):67-81. PubMed ID: 17552943
[TBL] [Abstract][Full Text] [Related]
43. Vertebral anomalies and cartilaginous tracheal sleeve in three patients with Pfeiffer syndrome carrying the S351C FGFR2 mutation.
Gonzales M; Heuertz S; Martinovic J; Delahaye S; Bazin A; Loget P; Pasquier L; Le Merrer M; Bonaventure J
Clin Genet; 2005 Aug; 68(2):179-81. PubMed ID: 15996217
[No Abstract] [Full Text] [Related]
44. Proline to arginine mutations in FGF receptors 1 and 3 result in Pfeiffer and Muenke craniosynostosis syndromes through enhancement of FGF binding affinity.
Ibrahimi OA; Zhang F; Eliseenkova AV; Linhardt RJ; Mohammadi M
Hum Mol Genet; 2004 Jan; 13(1):69-78. PubMed ID: 14613973
[TBL] [Abstract][Full Text] [Related]
45. [Frequent missense mutations of fibroblast growth factor receptor (FGFR) gene families in craniofacial syndromes in Japanese patients].
Ishigaki M; Wada C; Toyo-oka Y; Yamabe H; Ohnuki Y; Takada F; Yamazaki Y; Ohtani H
Rinsho Byori; 1996 May; 44(5):439-43. PubMed ID: 8676563
[TBL] [Abstract][Full Text] [Related]
46. Molecular diagnosis of bilateral coronal synostosis.
Mulliken JB; Steinberger D; Kunze S; Müller U
Plast Reconstr Surg; 1999 Nov; 104(6):1603-15. PubMed ID: 10541159
[TBL] [Abstract][Full Text] [Related]
47. Role of N-cadherin and protein kinase C in osteoblast gene activation induced by the S252W fibroblast growth factor receptor 2 mutation in Apert craniosynostosis.
Lemonnier J; Haÿ E; Delannoy P; Lomri A; Modrowski D; Caverzasio J; Marie PJ
J Bone Miner Res; 2001 May; 16(5):832-45. PubMed ID: 11341328
[TBL] [Abstract][Full Text] [Related]
48. Unclassifiable craniosynostosis phenotypes, FGFR2 Trp290 mutations, acanthosis nigricans, and unpaired cysteine mutations.
Cohen MM
Am J Med Genet; 2002 Nov; 113(1):1-3. PubMed ID: 12400057
[No Abstract] [Full Text] [Related]
49. Increased osteoblast apoptosis in apert craniosynostosis: role of protein kinase C and interleukin-1.
Lemonnier J; Haÿ E; Delannoy P; Fromigué O; Lomri A; Modrowski D; Marie PJ
Am J Pathol; 2001 May; 158(5):1833-42. PubMed ID: 11337381
[TBL] [Abstract][Full Text] [Related]
50. Dura in the pathogenesis of syndromic craniosynostosis: fibroblast growth factor receptor 2 mutations in dural cells promote osteogenic proliferation and differentiation of osteoblasts.
Ang BU; Spivak RM; Nah HD; Kirschner RE
J Craniofac Surg; 2010 Mar; 21(2):462-7. PubMed ID: 20489451
[TBL] [Abstract][Full Text] [Related]
51. Prenatal diagnosis of Pfeiffer syndrome type II.
Blaumeiser B; Loquet P; Wuyts W; Nöthen MM
Prenat Diagn; 2004 Aug; 24(8):644-6. PubMed ID: 15305355
[TBL] [Abstract][Full Text] [Related]
52. Presence of the Apert canonical S252W FGFR2 mutation in a patient without severe syndactyly.
Passos-Bueno MR; Richieri-Costa A; Sertié AL; Kneppers A
J Med Genet; 1998 Aug; 35(8):677-9. PubMed ID: 9719378
[TBL] [Abstract][Full Text] [Related]
53. Expression profiles of craniosynostosis-derived fibroblasts.
Carinci F; Bodo M; Tosi L; Francioso F; Evangelisti R; Pezzetti F; Scapoli L; Martinelli M; Baroni T; Stabellini G; Carinci P; Bellucci C; Lilli C; Volinia S
Mol Med; 2002 Oct; 8(10):638-44. PubMed ID: 12477974
[TBL] [Abstract][Full Text] [Related]
54. FGFR-associated craniosynostosis syndromes and gastrointestinal defects.
Hibberd CE; Bowdin S; Arudchelvan Y; Forrest CR; Brakora KA; Marcucio RS; Gong SG
Am J Med Genet A; 2016 Dec; 170(12):3215-3221. PubMed ID: 27481450
[TBL] [Abstract][Full Text] [Related]
55. Prenatal exclusion of Crouzon syndrome by mutation analysis of FGFR2.
Phupong V; Srichomthong C; Shotelersuk V
Southeast Asian J Trop Med Public Health; 2004 Dec; 35(4):977-9. PubMed ID: 15916101
[TBL] [Abstract][Full Text] [Related]
56. FGFs, their receptors, and human limb malformations: clinical and molecular correlations.
Wilkie AO; Patey SJ; Kan SH; van den Ouweland AM; Hamel BC
Am J Med Genet; 2002 Oct; 112(3):266-78. PubMed ID: 12357470
[TBL] [Abstract][Full Text] [Related]
57. Apert syndrome mutations in fibroblast growth factor receptor 2 exhibit increased affinity for FGF ligand.
Anderson J; Burns HD; Enriquez-Harris P; Wilkie AO; Heath JK
Hum Mol Genet; 1998 Sep; 7(9):1475-83. PubMed ID: 9700203
[TBL] [Abstract][Full Text] [Related]
58. Novel SNP at the common primer site of exon IIIa of FGFR2 gene causes error in molecular diagnosis of craniosynostosis syndrome.
Wong LJ; Chen TJ; Dai P; Bird L; Muenke M
Am J Med Genet; 2001 Aug; 102(3):282-5. PubMed ID: 11484208
[TBL] [Abstract][Full Text] [Related]
59. The Ser252Trp fibroblast growth factor receptor-2 (FGFR-2) mutation induces PKC-independent downregulation of FGFR-2 associated with premature calvaria osteoblast differentiation.
Lemonnier J; Delannoy P; Hott M; Lomri A; Modrowski D; Marie PJ
Exp Cell Res; 2000 Apr; 256(1):158-67. PubMed ID: 10739663
[TBL] [Abstract][Full Text] [Related]
60. Paternal origin of FGFR2 mutations in sporadic cases of Crouzon syndrome and Pfeiffer syndrome.
Glaser RL; Jiang W; Boyadjiev SA; Tran AK; Zachary AA; Van Maldergem L; Johnson D; Walsh S; Oldridge M; Wall SA; Wilkie AO; Jabs EW
Am J Hum Genet; 2000 Mar; 66(3):768-77. PubMed ID: 10712195
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
